The major research field of Prof. Yang’s group covers antibacterial agent, antidiabetic drug and antithrombotic drug discovery, new method and new process for drug synthesis, and the group has rich experience in innovative drug research. In 2009, the first new fluoroquinolone antibacterial agent with independent intellectual property―antofloxacin hydrochloride was successfully developed by Yang’s group. It is recognized as the landmark achievement of the “Key New Drug Creation and Manufacturing Program” of the “Eleventh Five-year Plan” in China, filling up the innovation gap in this field in more than 40 years. Antofloxacin hydrochloride has a better safety profile and pharmacokinetic property and its successful marketing is of great importance to the promotion of national innovative drug research and self-innovative ability in China.
Prof. Yang won the 2013 China Pharmacy Development Award-Innovative Drugs Award-Outstanding Achievement Award. In 2010, he won the title of “2007-2009 Advanced Worker in Shanghai (Model Worker)”. In 2010, he won the IBC China Drug Discovery of the Year Award.
Contact:Miss Jiang
Telephone:028-87014968
Email:xiameijiang@hyperwaypharma.com
Address:8Th Floor, Building B4, Tianfu Life Science Park, No.88, Keyuan South Road, Hi-Tech Zone, Chengdu, Sichuan